Drug intelligence / Profile preview

5alpha-androstane-3alpha,17beta-diol

Development stage
Unknown
Modality
Small Molecules
01

Overview

5alpha-androstane-3alpha,17beta-diol is a synthetic or endogenous steroid belonging to the class of androgens and derivatives. It is a C19 steroid hormone with hydroxyl groups at the 3-alpha and 17-beta positions. This compound is a metabolite of dihydrotestosterone (DHT) and exhibits androgenic activity by favoring the development of masculine characteristics. It also has significant effects on scalp and body hair in humans. Notably, it can act as an agonist at estrogen receptor beta (ERβ), influencing neuroendocrine regulation such as inhibition of hypothalamic-pituitary-adrenal (HPA) axis reactivity to stress via ERβ activation in the paraventricular nucleus (PVN) of the hypothalamus[2][9]. There are no approved medical indications for this compound; it is considered experimental.

Other names
3alpha-androstanediol3alpha,17beta-dihydroxy-5alpha-androstanedihydroandrosteronehombreol17beta-dihydroandrosterone5a-androstane-3a,17b-diol5α-androstane-3α,17β-diol
02

Targets

ESR2 (ERβ)AR (Adrenergic receptors)

Beyond the preview

Go deeper on 5alpha-androstane-3alpha,17beta-diol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5alpha-androstane-3alpha,17beta-diol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call